TITLE

Data Support RP for High-Risk PCa

AUTHOR(S)
CHARNOW, JODY A.
PUB. DATE
May 2013
SOURCE
Renal & Urology News;May2013, Vol. 12 Issue 5, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the study conducted by the researchers from Martini-Clinic Prostate Cancer Center in Hamburg, Germany on patients with high-risk prostate cancer (PCa). It mentions that complete surgical resection and biochemical recurrence (BCR) and metastases-free survival can be achieved in patients. It states that patients should not be denied with radical prostatectomy (RP). It also emphasizes that patients who experienced BCR progressed to metastases.
ACCESSION #
87627704

 

Related Articles

  • Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy. Patel, Parth; Patel, Jay; Siddiqui, Sameer // Case Reports in Urology;3/12/2015, Vol. 2015, p1 

    While cutaneous metastases are already extremely rare in primary metastatic prostatic adenocarcinoma, cutaneous manifestations in recurrent prostate cancer have rarely been described prior to this report. Here we present the case report of a 93-year-old male who underwent radical prostatectomy...

  • Possible Risk Factors Associated with Relapse in Patients Treated with Neoadjuvant Chemohormonal Therapy for High Risk Prostate Cancer. R. S. Bhatt; Werner, L.; Regan, M. M.; Yannucci, J.; Ko, Y-J.; Wang, H-Y.; Rosen, S.; Genega, E.; Morrissey, M-E.; Duggan, S.; Vazquez, C.; Sanda, M.; DeWolf, W.; Balk, S.; Yuan, X.; Bubley, G. J. // Open Prostate Cancer Journal;2011, Vol. 4, p6 

    Objectives: To perform a pilot hypothesis generating study of neoadjuvant docetaxel, estramustine, and androgen deprivation therapy for high-risk patients prior to radical prostatectomy. Patients and Methods: Twenty-eight patients received 4 cycles of docetaxel and estramustine administered on...

  • Tumor size in prostate specimen predicts recurrence. Tennant, Scott // Urology Times;Jan2001, Vol. 29 Issue 1, p19 

    Reports on the results of a study conducted by researcher Peter A. Humphrey and colleagues from the Washington University School of Medicine in Saint Louis, Missouri, which found out that tumor size in prostate cancer specimen predicts recurrence after prostatectomy. Prognostic value of the...

  • Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States. Miller, David C.; Gruber, Stephen B.; Hollenbeck, Brent K.; Montie, James E.; Wei, John T. // JNCI: Journal of the National Cancer Institute;8/16/2006, Vol. 98 Issue 16, p1134 

    Background: The frequently indolent nature of early-stage prostate cancer in older men and in men with low- or moderate-grade tumors and the demonstration that the survival benefits of radical prostatectomy are primarily among men younger than 65 years have led to concerns about prostate cancer...

  • The malignant adenoma: when to operate and when to watch. Mitchell, Peter J.; Haboubi, Najib Y. // Surgical Endoscopy;Jul2008, Vol. 22 Issue 7, p1563 

    Adenomas are the precursors to colorectal cancer. Malignant adenomas represent an early form of colorectal cancer, in which cancer has invaded by direct continuity through the muscularis mucosa into the submucosa. The management of these malignant adenomas depends upon their histological risk...

  • New formula predicts risk of prostate cancer relapse. Josefson, Deborah // BMJ: British Medical Journal (International Edition);05/15/99, Vol. 318 Issue 7194, p1309 

    Focuses on a devised formula developed by urologists have that will predict the risk of a recurrence of prostate cancer after radical prostatectomy. Examination on the concentration of prostate specific antigen after surgery; Factors which predicted metastatic disease; Indications of high and...

  • Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy? Furusato, B.; Rosner, I. L.; Osborn, D.; Ali, A.; Srivastava, S.; Davis, C. J.; Sesterhenn, I. A.; McLeod, D. G. // Journal of Clinical Pathology;Sep2008, Vol. 61 Issue 9, p1038 

    Aims: The objective of this study was to determine the incidence of prostate specific antigen (PSA) relapse in patients with low volume prostate cancer following radical prostatectomy. Methods: Between 1993 and 2001, 50 of 717 patients had total tumour volumes of less than 0.5 cm3 following...

  • Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Takamura, M.; Koga, K.; Osuga, Y.; Takemura, Y.; Hamasaki, K.; Hirota; Yoshino, O.; Taketani, Y. // Human Reproduction;Dec2009, Vol. 24 Issue 12, p3042 

    BACKGROUND: The aim of this study was to evaluate the impact of post-operative oral contraceptives (OCs) use on the rate of recurrence after laparoscopic excision of ovarian endometrioma.

  • Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up. FREGA, A.; SESTI, F.; SOPRACORDEVOLE, F.; BIAMONTI, A.; SCIRPA, P.; MILAZZO, G. N.; CATALANO, A.; ASSORGI, C.; LOMBARDI, D.; GENTILE, M.; MANIGLIO, P.; RICCIARDI, E.; COZZA, G.; MARZIANI, R.; MOSCARINI, M. // European Review for Medical & Pharmacological Sciences;Apr2013, Vol. 17 Issue 7, p936 

    BACKGROUND: Vulvar intraepithelial neoplasia (VIN) is a premalingnant condition. For long time, surgery was considered the first-line therapy in the treatment of high grade VIN. Imiquimod was recently introduced as an alternative to surgery. AIM: To compare the overall complete response, the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics